Mie Inao
Morohongo, 3500495, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
A case of non-HIV pneumocystis pneumonia in a patient with cirrhosis-associated immune dysfunction.
Journal: Clinical journal of gastroenterology
Published: March 19, 2025
Safety, feasibility, and acceptability of physiotherapy combined with strength training using active video games for older patients with musculoskeletal conditions.
Journal: Disability and rehabilitation. Assistive technology
Published: August 24, 2022
Machine learning in primary biliary cholangitis: A novel approach for risk stratification.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: May 23, 2021
Furosemide as a factor to deteriorate therapeutic efficacy of rifaximin in patients with decompensated cirrhosis.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: June 19, 2020
Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: June 19, 2020
A validation study of the Ursodeoxycholic Acid Response Score in Japanese patients with primary biliary cholangitis.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 25, 2020
Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary Cholangitis.
Journal: Hepatology (Baltimore, Md.)
Published: March 26, 2018
Significance of NS5B Substitutions in Genotype 1b Hepatitis C Virus Evaluated by Bioinformatics Analysis.
Journal: Scientific reports
Published: November 13, 2017
Chronic hepatitis caused by hepatitis C virus showing a discrepancy between serogroup and genotype because of intergenotypic 2b/1b recombination: A pitfall in antiviral therapy with direct-acting antivirals.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: July 26, 2017
Retreatment with sofosbuvir/ledipasvir with or without lead-in interferon-β injections in patients infected with genotype 1b hepatitis C virus after unsuccessful daclatasvir/asunaprevir therapy.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: July 18, 2017
"Reversi-type virologic failure" involved in the development of non-structural protein 5A resistance-associated variants (RAVs) in patients with genotype 1b hepatitis C carrying no signature RAVs at baseline.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: December 14, 2016
Last Updated: 09/26/2026